sNFl and sGFAP Predict MS Disability in Unique Ways

Serum glial fibrillary acidic protein (sGFAP) is quickly maturing as a biomarker to predict disability in patients with multiple sclerosis (MS).
MDedge News

source https://www.medscape.com/s/viewarticle/snfl-and-sgfap-predict-ms-disability-unique-ways-2024a1000i8x?src=rss